Press Release|

SHL to attend 2022 NSTC Science Train Program

Shl Medical Sebastian Feng Attended the Press Conference of Science Train Taiwan 2022
Shl Medical Sebastian Feng Attended the Press Conference of Science Train by NSTC Taiwan 2022, as part of SHL’s CSR effort

SHL Medical is excited to announce our first-time participation in the NSTC Science Train Program, a program organized by Taiwan’s National Science and Technology Council. The Science Train program features a specially designed train that travels around Taiwan, enabling elementary schoolers from 16 cities to board and follow instructors in conducting science experiments on the train.

The program aims to inspire elementary schoolers’ curiosity towards science as well as raising their awareness of science in their daily lives.

SHL strives to maintain its position as the market leader in the drug delivery industry while fulfilling its stated purpose of “Enabling Patients’ Independence” by offering patient-centric innovations and developing leading technology. It will bring this commitment to the Science Train. The SHL-designated carriage will introduce youth to key physics concepts through experiments and activities focusing on the mechanisms of an autoinjector.

Shl Medical Sebastian Feng Attended the Press Conference of Science Train Taiwan 2022-Group photo
Shl Medical Sebastian Feng Attended the Press Conference of Science Train Taiwan 2022-Group photo

Sebastian Feng, General Manager of SHL Medical Taiwan, commented, “SHL Medical is delighted to attend the Science Train Program this year. We believe human-centered innovations support the enhancement of social wellness, in which patients receive the necessary drug treatment in the comfort of their homes. We hope this opportunity to actively engage with today’s youth will really inspire their interest in science. It is exciting to think that some participants should form part of the next-generation MedTech talent.”

With locations in Taiwan for over 30 years, SHL continuously collaborates with various foundation and institutions in promoting the education and health of the younger generation. Besides the Science Train Program in 2022, SHL has cooperated with universities to provide apprenticeships since 2012.

Participation in the NSTC Science Train Program demonstrates SHL’s dedication to our Environmental Social Governance (ESG) goals in promoting equal access to quality education for all levels. SHL’s sustainability initiatives are supported by three focus areas: Product, People, and Planet. By being responsible for developing sustainable product designs, and promising to fulfil a sustainable society, we reinforce our commitment to preserving a sustainable environment.

Photo credit: 2022 NSTC Science Train

About SHL Medical

As a world-leading solutions provider of advanced drug delivery systems, SHL Medical is the partner of choice for many leading pharma and biotech companies. Driven by our company purpose – Enabling Patients’ Independence – we offer patient-centric solutions for the design, development, and manufacturing of autoinjectors, pen injectors, as well as innovative specialty delivery systems for large-volume and high-viscosity formulations. We also offer final assembly, labeling, and packaging solutions for our drug delivery systems.  ​

In response to the rising trend in home therapy, SHL has increased developmental work in the digital healthcare sector to help improve the drug delivery ecosystem

Located across Switzerland, Taiwan, Sweden, and the US, our global team of experts collaborate seamlessly as one team in utilizing our comprehensive in-house manufacturing capabilities. Our solutions offer customization and optimization for each project while proactively weaving sustainability-driven measures into our designs and processes to contribute to a cleaner earth.​

For additional information, visit www.shl-medical.com

Media contact: info@shl-medical.com

Share:

Related News

SHL Medical, a world-leading solutions provider of advanced drug delivery systems such as autoinjectors, pen injectors, and innovative specialty delivery systems has announced a strategic partnership with Grand River Aseptic Manufacturing (GRAM), a highly regarded contract development and manufacturing organization (CDMO) specializing in sterile injectable biologics and scalable pharmaceutical manufacturing solutions tailored to diverse client needs.